310 related articles for article (PubMed ID: 19018520)
21. Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating δ9-tetrahydrocannabinol.
Lile JA; Kelly TH; Hays LR
Clin Neuropharmacol; 2010; 33(5):235-42. PubMed ID: 20838217
[TBL] [Abstract][Full Text] [Related]
22. Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.
Wiley JL; Lefever TW; Cortes RA; Marusich JA
Pharmacol Biochem Behav; 2014 Sep; 124():123-8. PubMed ID: 24887450
[TBL] [Abstract][Full Text] [Related]
23. Discriminative stimulus properties of Cannabis sativa terpenes in rats.
Carey LM; Ghodrati S; France CP
Behav Pharmacol; 2024 Jun; 35(4):161-171. PubMed ID: 38660819
[TBL] [Abstract][Full Text] [Related]
24. An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.
Kollins SH; Schoenfelder EN; English JS; Holdaway A; Van Voorhees E; O'Brien BR; Dew R; Chrisman AK
J Subst Abuse Treat; 2015 Jan; 48(1):96-103. PubMed ID: 25175495
[TBL] [Abstract][Full Text] [Related]
25. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
26. Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women.
Babalonis S; Lile JA; Martin CA; Kelly TH
Behav Pharmacol; 2011 Sep; 22(5-6):441-9. PubMed ID: 21808190
[TBL] [Abstract][Full Text] [Related]
27. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.
Vann RE; Warner JA; Bushell K; Huffman JW; Martin BR; Wiley JL
Eur J Pharmacol; 2009 Aug; 615(1-3):102-7. PubMed ID: 19470387
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the discriminative stimulus and response rate effects of
Wiley JL; Lefever TW; Marusich JA; Craft RM
Drug Alcohol Depend; 2017 Mar; 172():51-59. PubMed ID: 28130989
[TBL] [Abstract][Full Text] [Related]
29. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
30. Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
Järbe TU; Li C; Vadivel SK; Makriyannis A
Psychopharmacology (Berl); 2008 Jul; 198(4):467-78. PubMed ID: 18264696
[TBL] [Abstract][Full Text] [Related]
31. Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.
McMahon LR
Drug Alcohol Depend; 2016 Aug; 165():87-93. PubMed ID: 27289270
[TBL] [Abstract][Full Text] [Related]
32. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
Stoops WW; Lile JA; Glaser PE; Rush CR
Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
[TBL] [Abstract][Full Text] [Related]
34. Effects of 20 mg oral Δ(9) -tetrahydrocannabinol on the olfactory function of healthy volunteers.
Walter C; Oertel BG; Ludyga D; Ultsch A; Hummel T; Lötsch J
Br J Clin Pharmacol; 2014 Nov; 78(5):961-9. PubMed ID: 24802974
[TBL] [Abstract][Full Text] [Related]
35. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.
Lundahl LH; Greenwald MK
Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933
[TBL] [Abstract][Full Text] [Related]
36. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.
Hruba L; Ginsburg BC; McMahon LR
J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500
[TBL] [Abstract][Full Text] [Related]
37. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys.
Wiley JL; Huffman JW; Balster RL; Martin BR
Drug Alcohol Depend; 1995 Nov; 40(1):81-6. PubMed ID: 8746928
[TBL] [Abstract][Full Text] [Related]
39. Δ
Rowton SS; Rocha BA; Porter IE
J Pharmacol Toxicol Methods; 2020; 106():106937. PubMed ID: 33096236
[TBL] [Abstract][Full Text] [Related]
40. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]